Avadel Pharmaceuticals (AVDL) Payables (2016 - 2022)
Historic Payables for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Q3 2022 value amounting to $2.5 million.
- Avadel Pharmaceuticals' Payables fell 6393.66% to $2.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $2.5 million, marking a year-over-year decrease of 6393.66%. This contributed to the annual value of $7.7 million for FY2021, which is 16172.46% up from last year.
- Per Avadel Pharmaceuticals' latest filing, its Payables stood at $2.5 million for Q3 2022, which was down 6393.66% from $7.3 million recorded in Q2 2022.
- Avadel Pharmaceuticals' Payables' 5-year high stood at $15.9 million during Q1 2018, with a 5-year trough of $2.5 million in Q3 2022.
- Moreover, its 5-year median value for Payables was $5.1 million (2021), whereas its average is $6.1 million.
- Its Payables has fluctuated over the past 5 years, first tumbled by 7390.92% in 2019, then skyrocketed by 16172.46% in 2021.
- Quarter analysis of 5 years shows Avadel Pharmaceuticals' Payables stood at $3.5 million in 2018, then soared by 74.14% to $6.1 million in 2019, then crashed by 51.9% to $2.9 million in 2020, then surged by 161.72% to $7.7 million in 2021, then crashed by 67.72% to $2.5 million in 2022.
- Its last three reported values are $2.5 million in Q3 2022, $7.3 million for Q2 2022, and $6.0 million during Q1 2022.